View Mobile Friendly Conference List »

Setting new standards in information exchange for the pharmaceutical and biotech industry


Robert M. Califf, MD, MACC is Confirmed to Keynote at the Launch of Clinical Trial Collaborations

  • December 3, 2015

  • We are delighted to announce that Robert M. Califf, MD, MACC, Deputy Commissioner for Medical Products and Tobacco for the FDA is confirmed to keynote at Clinical Trials Collaborations on March 22nd in Boston, MA. Dr Califf will provide insights into the vision, goals and challenges for the FDA in 2016 as well as provide thoughts on the outsourcing environment and what industry can do to help.

    Clinical Trial Collaborations is presented jointly for the first time by Centerwatch and the Conference Forum. The Summit is chaired by Ken Getz, Director, Sponsored Research Programs at Tufts CSDD and provides a truly strategic level event on clinical outsourcing and the future of collaborations to drive more efficient R&D operations. The conference presents powerful ideas for R&D operations, CRO and Site executives to find new ways to collaborate.

    Clinical Trial Collaborations will be held at the Boston Marriott Cambridge Hotel on March 21-21, 2016 in Cambridge, MA. In the spirit of the biopharma boom and intellectual power between Harvard and MIT, Cambridge seemed the logical choice for a clinical operations conference.

    About Robert M. Califf, MD, MACC

    UPDATED_Califf photoRobert M. Califf, MD, MACC, was named Deputy Commissioner for Medical Products and Tobacco for the Food and Drug Administration (FDA) in February of 2015. Dr. Califf provides executive leadership to the Center for Drug Evaluation and Research, the Center for Biologics Evaluation and Research, the Center for Devices and Radiological Health, and the Center for Tobacco Products. He also oversees the Office of Special Medical Programs and provides direction for cross-cutting clinical, scientific, and regulatory initiatives, including precision medicine, combination products, orphan drugs, pediatric therapeutics, and the advisory committee system.

    Prior to joining the FDA, Dr. Califf was a professor of medicine and vice chancellor for clinical and translational research at Duke University. He also served as director of the Duke Translational Medicine Institute and founding director of the Duke Clinical Research Institute. A nationally and internationally recognized expert in cardiovascular medicine, health outcomes research, healthcare quality, and clinical research, Dr. Califf has led many landmark clinical trials and is one of the most frequently cited authors in biomedical science, with more than 1,200 publications in the peer-reviewed literature.

    Dr. Califf has served on the Institute of Medicine (IOM) committees that recommended Medicare coverage of clinical trials and the removal of ephedra from the market, as well as on the IOM Committee on Identifying and Preventing Medication Errors and the IOM Health Sciences Policy Board. He has served as a member of the FDA Cardiorenal Advisory Panel and FDA Science Board’s Subcommittee on Science and Technology. Dr. Califf has also served on the Board of Scientific Counselors for the National Institutes of Health and the National Library of Medicine, as well as on advisory committees for the National Cancer Institute, the National Heart, Lung, and Blood Institute, the National Institute of Environmental Health Sciences and the Council of the National Institute on Aging.

    While at Duke, Dr. Califf led major initiatives aimed at improving methods and infrastructure for clinical research, including the Clinical Trials Transformation Initiative (CTTI), a public-private partnership co-founded by the FDA and Duke. He also served as the principal investigator for Duke’s Clinical and Translational Science Award and the NIH Health Care Systems Research Collaboratory coordinating center.

    Dr. Califf is a graduate of Duke University School of Medicine. He completed a residency in internal medicine at the University of California, San Francisco and a fellowship in cardiology at Duke.

    About CenterWatch

    CenterWatch logoSince 1994, CenterWatch, has been the recognized global leader in providing clinical trials information to a broad and influential spectrum of clinical research professionals ranging from sponsors and CROs to research sites and niche providers. For more information, visit

    About The Conference Forum

    conference-forumThe Conference Forum has a very specific focus – developing specialized events, both public and private as well as research groups and advisory boards, for professionals in the life science and healthcare industries. Their mission is to create the best content, exchange ideas and solutions among peers and provide quality networking for Pharmaceutical and Biotech professionals. For more information, visit